Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Etienne J. M. Janssen"'
Autor:
Anne T. M. Dittrich, Etienne J. M. Janssen, Joyce Geelen, Karlijn Bouman, Leanne M. Ward, Jos M. T. Draaisma
Publikováno v:
Applied Sciences, Vol 13, Iss 7, p 4491 (2023)
By definition, children constitute a vulnerable population, especially when they are chronically ill and/or disabled. A characteristic of chronically ill and disabled children is that they also suffer from indirect effects of their disease, such as i
Externí odkaz:
https://doaj.org/article/82d755aaabd84756879ee2c97f8e5513
Autor:
Carlien A. M. Bennebroek, Judith van Zwol, Giorgio L. Porro, Rianne Oostenbrink, Anne T. M. Dittrich, Annabel L. W. Groot, Jan W. Pott, Etienne J. M. Janssen, Noël J. Bauer, Maria M. van Genderen, Peerooz Saeed, Maarten H. Lequin, Pim de Graaf, Antoinette Y. N. Schouten-van Meeteren
Publikováno v:
Bennebroek, C A M, van Zwol, J, Porro, G L, Oostenbrink, R, Dittrich, A T M, Groot, A L W, Pott, J W, Janssen, E J M, Bauer, N J, van Genderen, M M, Saeed, P, Lequin, M H, de Graaf, P & Schouten-van Meeteren, A Y N 2022, ' Impact of Bevacizumab on Visual Function, Tumor Size, and Toxicity in Pediatric Progressive Optic Pathway Glioma : A Retrospective Nationwide Multicentre Study ', Cancers, vol. 14, no. 24, 6087 . https://doi.org/10.3390/cancers14246087
Cancers, 14(24):6087. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 14
Cancers; Volume 14; Issue 24; Pages: 6087
Cancers, 14(24):6087. MDPI AG
Cancers, 14, 24
Cancers, 14(24):6087. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 14
Cancers; Volume 14; Issue 24; Pages: 6087
Cancers, 14(24):6087. MDPI AG
Cancers, 14, 24
BACKGROUNDS: Bevacizumab (BVZ) is used as a subsequent line of treatment for pediatric optic pathway glioma (OPG) in the case of progression. Data on the treatment effect concerning tumor progression and visual function are scarce and nationwide stud
Publikováno v:
Clinical Dysmorphology, 30(1), 58-61. LIPPINCOTT WILLIAMS & WILKINS
Publikováno v:
Clinical dysmorphology. 30(1)